DIABETES - LIRAGLUTIDE

NICE Appraisal

TA203  Liraglutide for the treatment of type 2 diabetes (October 2010)

 

DSU Report

Liraglutide for the treatment of type 2 diabetes: A review of the Mixed Treatment Comparison (MTC) analysis provided by the manufacturer of liraglutide in response to the appraisal consultation document (ACD) (April 2010)

 

To receive notification when new reports or documents are uploaded to this website, please join our mailing list by entering your details on the right of this page or follow us on Twitter @NICE_DSU